Actively Recruiting
Global Patient-Powered Registry for Appendix Cancer and Pseudomyxoma Peritonei Collecting Long-Term Data to Support Research and Clinical Trials
Led by Appendix Cancer Pseudomyxoma Peritonei Research Foundation · Updated on 2026-08-17
10000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This observational study is a global, patient-powered registry designed to gather detailed information about individuals affected by appendix cancer and Pseudomyxoma Peritonei PMP. The study aims to improve understanding of these rare diseases by tracking their characteristics, clinical course, treatment patterns, and progression over time. It supports research by providing a rich data source to help develop care recommendations and accelerate new treatment discoveries. Participants, caregivers, or authorized representatives contribute data through online surveys, including uploading medical documents such as pathology reports and genomic sequencing results. The registry collects both retrospective and prospective information on demographics, medical history, treatment details, disease progression, and quality of life. Participants are encouraged to update their information periodically to capture changes over time. Throughout the study, researchers assess various outcomes including the natural history of appendix cancer and PMP, disease characteristics, treatment history, diagnosis, disease progression, care management, and signs and symptoms up to five years. The registry is managed by the ACPMP Research Foundation and hosted on the NORD IAMRARE platform under ethical oversight to ensure data protection and appropriate research use. The study runs from February 2026 to February 2030.
CONDITIONS
Brief Title
The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
Research Team
M
Margaret Najarian
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here